166 related articles for article (PubMed ID: 34174981)
1. Prognostic and Predictive Implications of Cytogenetics and Genomics.
Ljungström V; Baliakas P
Hematol Oncol Clin North Am; 2021 Aug; 35(4):703-713. PubMed ID: 34174981
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Nguyen-Khac F; Balogh Z; Chauzeix J; Veronese L; Chapiro E
Curr Res Transl Med; 2023; 71(4):103410. PubMed ID: 38039634
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetics in the management of chronic lymphocytic leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Nguyen-Khac F; Borie C; Callet-Bauchu E; Eclache V; Struski S
Ann Biol Clin (Paris); 2016 Oct; 74(5):561-567. PubMed ID: 27628190
[TBL] [Abstract][Full Text] [Related]
5. The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature.
Jarošová M; Plevová K; Kotašková J; Doubek M; Pospíšilová Š
Leuk Lymphoma; 2019 Oct; 60(10):2348-2355. PubMed ID: 30773964
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral genetic heterogeneity and number of cytogenetic aberrations provide additional prognostic significance in chronic lymphocytic leukemia.
Yi S; Li Z; Zou D; An G; Cui R; Zhong S; Li H; Xiong W; Li C; Chen W; Liu W; Lv R; Yu Z; Wang H; Xu Y; Zhou K; Ru K; Wang J; Cheng T; Qiu L
Genet Med; 2017 Feb; 19(2):182-191. PubMed ID: 27467457
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry.
Mato A; Nabhan C; Kay NE; Lamanna N; Kipps TJ; Grinblatt DL; Flowers CR; Farber CM; Davids MS; Kiselev P; Swern AS; Bhushan S; Sullivan K; Flick ED; Sharman JP
Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):114-124.e2. PubMed ID: 29352719
[TBL] [Abstract][Full Text] [Related]
8. Genomic data in prognostic models-what is lost in translation? The case of deletion 17p and mutant TP53 in chronic lymphocytic leukaemia.
Chin-Yee B; Sadikovic B; Chin-Yee IH
Br J Haematol; 2020 Mar; 188(5):652-660. PubMed ID: 30836431
[TBL] [Abstract][Full Text] [Related]
9. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis.
Döhner H; Stilgenbauer S; Döhner K; Bentz M; Lichter P
J Mol Med (Berl); 1999 Feb; 77(2):266-81. PubMed ID: 10023780
[TBL] [Abstract][Full Text] [Related]
10. An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness.
Rigolin GM; Formigaro L; Cavallari M; Quaglia FM; Lista E; Urso A; Guardalben E; Martinelli S; Saccenti E; Bassi C; Lupini L; Bardi MA; Volta E; Tammiso E; Melandri A; Negrini M; Cavazzini F; Cuneo A
Oncotarget; 2017 Apr; 8(17):28008-28020. PubMed ID: 28427204
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.
Ma ES
Methods Mol Biol; 2017; 1541():279-293. PubMed ID: 27910030
[TBL] [Abstract][Full Text] [Related]
13. Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia.
Houldsworth J; Guttapalli A; Thodima V; Yan XJ; Mendiratta G; Zielonka T; Nanjangud G; Chen W; Patil S; Mato A; Brown JR; Rai K; Chiorazzi N; Chaganti RS
Leuk Lymphoma; 2014 Apr; 55(4):920-8. PubMed ID: 24047479
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
[TBL] [Abstract][Full Text] [Related]
15. Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization.
Gerrie AS; Huang SJ; Bruyere H; Dalal C; Hrynchak M; Karsan A; Ramadan KM; Smith AC; Tyson C; Toze CL; Gillan TL
Cancer Genet; 2014; 207(7-8):316-25. PubMed ID: 25441686
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Baliakas P; Jeromin S; Iskas M; Puiggros A; Plevova K; Nguyen-Khac F; Davis Z; Rigolin GM; Visentin A; Xochelli A; Delgado J; Baran-Marszak F; Stalika E; Abrisqueta P; Durechova K; Papaioannou G; Eclache V; Dimou M; Iliakis T; Collado R; Doubek M; Calasanz MJ; Ruiz-Xiville N; Moreno C; Jarosova M; Leeksma AC; Panayiotidis P; Podgornik H; Cymbalista F; Anagnostopoulos A; Trentin L; Stavroyianni N; Davi F; Ghia P; Kater AP; Cuneo A; Pospisilova S; Espinet B; Athanasiadou A; Oscier D; Haferlach C; Stamatopoulos K;
Blood; 2019 Mar; 133(11):1205-1216. PubMed ID: 30602617
[TBL] [Abstract][Full Text] [Related]
17. Genetic features of B-cell chronic lymphocytic leukemia.
Stilgenbauer S; Lichter P; Döhner H
Rev Clin Exp Hematol; 2000 Mar; 4(1):48-72. PubMed ID: 11486330
[TBL] [Abstract][Full Text] [Related]
18. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
[TBL] [Abstract][Full Text] [Related]
19. Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalities.
Jimenez-Zepeda VH; Chng WJ; Schop RF; Braggio E; Leis JF; Kay N; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):467-76. PubMed ID: 23876845
[TBL] [Abstract][Full Text] [Related]
20. Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.
Ouillette P; Saiya-Cork K; Seymour E; Li C; Shedden K; Malek SN
Clin Cancer Res; 2013 Jun; 19(11):2893-904. PubMed ID: 23620403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
